Pivotal bioVenture Partners Investment Advisor LLC 13F Holdings
CIK 0001844645 · SAN FRANCISCO, CA
As of Sep 30, 2025, Pivotal bioVenture Partners Investment Advisor LLC reported 10 positions worth
CIK 0001844645 · SAN FRANCISCO, CA
As of Sep 30, 2025, Pivotal bioVenture Partners Investment Advisor LLC reported 10 positions worth
73.0M in its SEC Form 13F filing.
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| VAXCYTE INC | PCVX | Healthcare | 1,372,425 | $49.4M | 28.58% |
| OCULIS HOLDING AG | OCS | Healthcare | 2,300,774 | $40.4M | 23.38% |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 2,120,508 | $40.0M | 23.11% |
| ZENAS BIOPHARMA INC | ZBIO | Healthcare | 779,045 | 7.3M | 10.00% |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 1,256,782 | 1.5M | 6.65% |
| IMMUNOME INC | IMNM | — | 502,512 | $5.9M | 3.40% |
| BIOAGE LABS INC | BIOA | Healthcare | 653,374 | $3.8M | 2.22% |
| RECURSION PHARMACEUTICALS INC | RXRX | Healthcare | 595,518 | $2.9M | 1.68% |
| RALLYBIO CORP | RLYB | Healthcare | 2,404,644 | .2M | 0.69% |
| BOLT BIOTHERAPEUTICS INC | BOLT | Healthcare | 94,573 | $503.1K | 0.29% |